LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 34,137 | 10,951 | 9,072 | 5,805 | 7,591 |
| Cost of Goods | 6,331 | 3,806 | 2,489 | 808 | 716 |
| Gross Profit | 27,806 | 7,145 | 6,583 | 4,997 | 6,875 |
| Operating Expenses | 10,644 | 11,341 | 16,599 | 18,266 | 18,051 |
| Operating Income | 17,493 | -3,390 | -9,527 | -12,461 | -10,460 |
| Interest Expense | 2,609 | 2,649 | 2,526 | 2,470 | 2,406 |
| Other Income | -448 | 2,561 | 293 | -661 | 4,275 |
| Pre-tax Income | 14,436 | -3,478 | -11,760 | -15,592 | -8,591 |
| Income Tax | 18 | N/A | 0 | 0 | N/A |
| Net Income Continuous | 14,418 | -3,478 | -11,760 | -15,592 | -8,591 |
| Net Income | $14,418 | $-3,478 | $-11,760 | $-15,592 | $-8,591 |
| EPS Basic Total Ops | 0.53 | -0.12 | -0.43 | -0.57 | -0.32 |
| EPS Basic Continuous Ops | 0.53 | -0.13 | -0.43 | -0.57 | -0.32 |
| EPS Diluted Total Ops | 0.42 | -0.12 | -0.43 | -0.57 | -0.32 |
| EPS Diluted Continuous Ops | 0.42 | -0.13 | -0.43 | -0.57 | -0.32 |
| EPS Diluted Before Non-Recurring Items | 0.42 | -0.13 | -0.43 | N/A | N/A |
| EBITDA(a) | $17,956 | $-2,811 | $-8,519 | $-11,369 | $-9,055 |